Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01414595 · ClinicalTrials.gov registry record

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
248
Enrollment target

NCT01414595 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 248 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01414595 has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
248 participants
Enrollment target

Study Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.

Interventions

  • GENETIC gene expression analysis
  • GENETIC DNA analysis
  • GENETIC RNA analysis
  • GENETIC DNA methylation analysis
  • GENETIC polymorphism analysis

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2012-03

What the Registry Record Tells You About NCT01414595

The ClinicalTrials.gov registry entry for NCT01414595 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.

NCT01414595 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01414595 about?

NCT01414595 is a clinical study titled "Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer". RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.

What is the current status of trial NCT01414595?

This trial is currently completed. The enrollment target is 248 participants. The study started on 2012-03.

What interventions are being tested in trial NCT01414595?

The interventions under investigation include: gene expression analysis (GENETIC), DNA analysis (GENETIC), RNA analysis (GENETIC), DNA methylation analysis (GENETIC), polymorphism analysis (GENETIC).

Who is sponsoring clinical trial NCT01414595?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.